醫藥玻璃容器市場規模、佔有率及成長分析（按材料、產品、藥物類型及地區分類）－2026-2033年產業預測

預計到 2024 年，醫藥玻璃包裝市場規模將達到 219.4 億美元，到 2025 年將達到 240.5 億美元，到 2033 年將達到 500.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 9.6%。

醫藥玻璃包裝市場的成長主要得益於醫藥產業的擴張以及消費者對玻璃材質的偏好，因為玻璃具有許多優良特性。這一趨勢的動力來自玻璃回收利用力度的加大，尤其是在已開發國家。醫藥玻璃容器對於儲存和包裝各種物質（包括強酸和強鹼）至關重要。技術創新發揮關鍵作用，物流公司不斷創新以提升其市場地位。此外，產業向永續包裝手法的轉變也反映了消費者對環保產品日益成長的需求。玻璃瓶因其100%可回收性和與內容物無反應的特性而成為一種永續的選擇。回收技術的進步有望降低成本，進一步推動玻璃在循環經濟中的應用，同時個人化包裝也越來越受歡迎。

醫藥玻璃包裝市場成長要素

生物製藥（例如單株抗體和疫苗）日益普及，是推動全球醫藥玻璃包裝市場成長的主要動力。這些生物製藥需要符合高安全性和無菌標準的包裝解決方案，以維持其療效。由於玻璃具有惰性、耐用性和能夠保持敏感藥物完整性等優點，因此通常被選為首選材料，這也顯著增加了醫療產業對管瓶和注射器的需求。因此，不斷擴張的生物製藥產業正在推動對先進玻璃包裝解決方案的強勁需求，從而促進市場擴張。

限制醫藥玻璃包裝市場發展的因素

製藥企業日益傾向於使用塑膠和金屬等替代材料進行包裝，這對製藥玻璃包裝市場構成了重大挑戰。這些替代材料通常更具成本效益、重量更輕、柔軟性，因此對尋求經濟實惠且用途廣泛的製藥公司極具吸引力。隨著企業在包裝選擇上優先考慮經濟實惠且適應性強的解決方案，對傳統玻璃包裝的需求可能會受到限制，進而影響製藥業玻璃包裝市場的整體成長。

醫藥玻璃包裝市場趨勢

目前，醫藥玻璃包裝市場正呈現顯著上升趨勢，這主要得益於生物製藥包裝需求的激增。疫苗和單株抗體等生物製藥的研發和廣泛應用，推動了對專用玻璃包裝解決方案的需求。管瓶和注射器因其能提供安全無菌的環境，確保這些敏感藥物的穩定性和有效性，而日益受到青睞。這種轉變不僅凸顯了先進包裝技術的必要性，也反映了整個製藥業對保護藥物完整性和提升病人安全的重視。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境
• 案例研究
• 專利分析
• 貿易分析

醫藥玻璃容器市場：依材質分類的市場規模及複合年成長率（2026-2033）

• 一型
• II 型
• III型

醫藥玻璃容器市場：依產品分類的市場規模及複合年成長率（2026-2033）

• 管瓶
  • 管瓶
  • 大號管瓶
• 瓶子
• 墨水匣和注射器
• 安瓿

醫藥玻璃容器市場：依藥物類型分類的市場規模及複合年成長率（2026-2033）

• 學名藥
• 品牌藥
• 生物製劑

醫藥玻璃容器市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Gerresheimer AG（Germany）
• Corning Incorporated（USA）
• Nipro Corporation（Japan）
• SGD SA（SGD Pharma）（France）
• Stolzle-Oberglas GmbH（CAG Holding GmbH）（Austria）
• Bormioli Pharma SpA（Italy）
• West Pharmaceutical Services Inc.（USA）
• Schott AG（Germany）
• Shandong Pharmaceutical Glass Co. Ltd.（China）
• Beatson Clark（United Kingdom）
• Arab Pharmaceutical Glass Co.（Egypt）
• Piramal Glass Private Limited（Piramal Group）（India）
• Sisecam Group（Turkey）
• Verallia（France）
• Shandong Yaowei Pharmaceutical Glass Co., Ltd.（China）
• Zhejiang Huachuang Pharmaceutical Glass Co., Ltd.（China）
• Changzhou Huaxing Pharmaceutical Glass Co., Ltd.（China）
• Jiangsu Huaxing Pharmaceutical Glass Co., Ltd.（China）
• Jiangsu Kaidi Pharmaceutical Glass Co., Ltd.（China）
• Jiangsu Yikang Pharmaceutical Glass Co., Ltd.（China）

結論與建議

Pharmaceutical Glass Packaging Market size was valued at USD 21.94 Billion in 2024 and is poised to grow from USD 24.05 Billion in 2025 to USD 50.07 Billion by 2033, growing at a CAGR of 9.6% during the forecast period (2026-2033).

The growth of the pharmaceutical glass packaging market is driven by the expansion of the pharmaceutical sector and consumer preference for glass due to its beneficial properties. Increasing glass recycling efforts, particularly in developed nations, complement this trend. Pharmaceutical glass containers are essential for storing and packaging various materials, including strong acids and alkalis. Technological advancements play a pivotal role, with logistics companies innovating to enhance market positioning. Additionally, the industry's shift toward sustainable packaging practices reflects growing consumer demand for eco-friendly options. Glass jars stand out as a sustainable choice, being 100% recyclable and non-reactive with contents. Enhanced recycling technologies are expected to lower costs, further encouraging the adoption of glass in the circular economy, while personalized packaging continues to rise in popularity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmaceutical Glass Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pharmaceutical Glass Packaging Market Segments Analysis

Global Pharmaceutical Glass Packaging Market is segmented by Material, Product, Drug Type and Region. Based on Material, the market is segmented into Type I, Type II, Type, III. Based on Product, the market is segmented into Vials, Bottles, Cartridges and Syringes, Ampoules. Based on Drug Type, the market is segmented into Generic, Branded, Biologic. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pharmaceutical Glass Packaging Market

The increasing prevalence of biologics, such as monoclonal antibodies and vaccines, serves as a key driver for the growth of the global pharmaceutical glass packaging market. These biologics require packaging solutions that meet high standards of safety and sterility to maintain their efficacy. This requirement significantly elevates the demand for glass vials and syringes in the healthcare industry, as glass is often preferred for its inert properties, durability, and ability to preserve the integrity of sensitive medications. Consequently, the expanding biopharmaceutical sector is fostering a robust need for advanced glass packaging solutions, thereby propelling market expansion.

Restraints in the Pharmaceutical Glass Packaging Market

The increasing preference for alternative materials like plastic and metal in pharmaceutical packaging presents a significant challenge to the pharmaceutical glass packaging market. These alternatives are often more cost-effective, lighter in weight, and offer greater flexibility, making them appealing to pharmaceutical manufacturers looking for economical and versatile options. As companies prioritize budget-friendly solutions and adaptability in their packaging choices, the demand for traditional glass packaging may face constraints, potentially impacting the overall growth of the glass packaging sector within the pharmaceutical industry.

Market Trends of the Pharmaceutical Glass Packaging Market

The Pharmaceutical Glass Packaging market is currently experiencing a significant upward trend, primarily driven by the surging demand for biologic drug packaging. With the rise in the development and utilization of biologics such as vaccines and monoclonal antibodies, there is an escalated need for specialized glass packaging solutions. Glass vials and syringes are increasingly favored due to their ability to provide a safe and sterile environment, ensuring the stability and efficacy of these sensitive pharmaceuticals. This shift not only emphasizes the necessity for advanced packaging technologies but also reflects the broader industry focus on safeguarding drug integrity and enhancing patient safety in the pharmaceutical sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis
• Trade Analysis

Pharmaceutical Glass Packaging Market Market Size by Material & CAGR (2026-2033)

• Market Overview
• Type I
• Type II
• Type III

Pharmaceutical Glass Packaging Market Market Size by Product & CAGR (2026-2033)

• Market Overview
• Vials
  • Small Vials
  • Large Vials
• Bottles
• Cartridges and Syringes
• Ampoules

Pharmaceutical Glass Packaging Market Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Generic
• Branded
• Biologic

Pharmaceutical Glass Packaging Market Size & CAGR (2026-2033)

• North America (Material, Product, Drug Type)
  • US
  • Canada
• Europe (Material, Product, Drug Type)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Material, Product, Drug Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Material, Product, Drug Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Product, Drug Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD SA (SGD Pharma) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stolzle-Oberglas GmbH (CAG Holding GmbH) (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bormioli Pharma S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Pharmaceutical Glass Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beatson Clark (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arab Pharmaceutical Glass Co. (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Glass Private Limited (Piramal Group) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sisecam Group (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verallia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Yaowei Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Huachuang Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Changzhou Huaxing Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Huaxing Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Kaidi Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Yikang Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation